- Home
- HSPO vs BLUE Comparison
HSPO vs BLUE Comparison
Compare HSPO & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSPO
- BLUE
- Stock Information
- Founded
- HSPO 2014
- BLUE 1992
- Country
- HSPO United States
- BLUE United States
- Employees
- HSPO N/A
- BLUE N/A
- Industry
- HSPO Blank Checks
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSPO Finance
- BLUE Health Care
- Exchange
- HSPO Nasdaq
- BLUE Nasdaq
- Market Cap
- HSPO 90.8M
- BLUE 82.2M
- IPO Year
- HSPO 2022
- BLUE 2013
- Fundamental
- Price
- HSPO $11.42
- BLUE $8.35
- Analyst Decision
- HSPO
- BLUE Hold
- Analyst Count
- HSPO 0
- BLUE 9
- Target Price
- HSPO N/A
- BLUE $49.14
- AVG Volume (30 Days)
- HSPO 2.8K
- BLUE 328.0K
- Earning Date
- HSPO 01-01-0001
- BLUE 11-14-2024
- Dividend Yield
- HSPO N/A
- BLUE N/A
- EPS Growth
- HSPO 2.63
- BLUE N/A
- EPS
- HSPO 0.28
- BLUE N/A
- Revenue
- HSPO N/A
- BLUE $53,120,000.00
- Revenue This Year
- HSPO N/A
- BLUE $145.88
- Revenue Next Year
- HSPO N/A
- BLUE $239.89
- P/E Ratio
- HSPO $40.54
- BLUE N/A
- Revenue Growth
- HSPO N/A
- BLUE 144.50
- 52 Week Low
- HSPO $11.42
- BLUE $5.80
- 52 Week High
- HSPO $11.90
- BLUE $38.40
- Technical
- Relative Strength Index (RSI)
- HSPO 49.79
- BLUE 49.21
- Support Level
- HSPO $11.33
- BLUE $7.96
- Resistance Level
- HSPO $11.72
- BLUE $8.75
- Average True Range (ATR)
- HSPO 0.09
- BLUE 0.69
- MACD
- HSPO -0.01
- BLUE -0.05
- Stochastic Oscillator
- HSPO 15.79
- BLUE 23.72
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.